Development of Alzheimer's disease

There are 2 papers on development of Alzheimer's disease in aging research: 1 observational study in people, 1 review.

Disease

2 papers study it198 more mention it4 findings

3 new papers in 30 daysSee all 200 papers on development of Alzheimer's disease

“their longitudinal changes were significantly associated with the development of Alzheimer's disease compared to controls over the 10-year follow-up”
Systemic inflammatory markers in ageing, Alzheimer's disease and other dementiasBrain : a journal of neurology2024doi:10.1093/brain/awae230
  • Humans1

Interventions

1

Nonsteroidal anti-inflammatory drugs

no changein humans1HR 1.2

1 study
  1. Nonsteroidal anti-inflammatory drugs showed no clear effect on development of Alzheimer's disease in humans (People without Alzheimer's disease at baseline) (HR 1.20, 95% CI 0.95–1.51; P = 0.15).

    “They also have no protective effect against the development of AD on their sustained use.”

    ReviewPeople without Alzheimer's disease at baseline

    Role of Nonsteroidal Anti-Inflammatory Drugs as a Protective Factor in Alzheimer's Disease: A Systematic Review and Meta-Analysis

    Neurology India

More on Nonsteroidal anti-inflammatory drugs

Associations

3

IL-6

mixedin humans1

1 study
  1. IL-6 is associated with development of Alzheimer's disease in humans (preclinical Alzheimer's disease participants versus controls).

    “their longitudinal changes were significantly associated with the development of Alzheimer's disease compared to controls over the 10-year follow-up”

    Humanspreclinical Alzheimer's disease participants versus controls10-year follow-upn = 290

    Systemic inflammatory markers in ageing, Alzheimer's disease and other dementias

    Brain : a journal of neurology

More on IL-6

Interleukin-1β

mixedin humans1

1 study
  1. Interleukin-1β is associated with development of Alzheimer's disease in humans (preclinical Alzheimer's disease participants versus controls).

    “their longitudinal changes were significantly associated with the development of Alzheimer's disease compared to controls over the 10-year follow-up”

    Humanspreclinical Alzheimer's disease participants versus controls10-year follow-upn = 290

    Systemic inflammatory markers in ageing, Alzheimer's disease and other dementias

    Brain : a journal of neurology

More on Interleukin-1β

Complement C3

mixedin humans1

1 study
  1. Complement C3 is associated with development of Alzheimer's disease in humans (preclinical Alzheimer's disease participants versus controls).

    “their longitudinal changes were significantly associated with the development of Alzheimer's disease compared to controls over the 10-year follow-up”

    Humanspreclinical Alzheimer's disease participants versus controls10-year follow-upn = 290

    Systemic inflammatory markers in ageing, Alzheimer's disease and other dementias

    Brain : a journal of neurology

More on Complement C3

Latest

Dec 2025: 14Jan 2026: 8Feb 2026: 1Mar 2026: 1Apr 2026: 5May 2026: 6Jun 2026: 4Jul 2026: 2Aug 2026: 2Sep 2026: 1Oct 2026: 1Nov 2026: 247 papers in 12 months

See all 200 papers on development of Alzheimer's disease